COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,398 Articles (22,816 medRxiv, 8,582 bioRxiv)

Most recent first Previous |  Page 815: Articles 8141-8150  | Next

A methodology to generate epidemic scenarios for emerging infectious diseases based on the use of key calendar events
Acuna-Zegarra, M. A., Santana-Cibrian, M., Rodriguez Hernandez-Vela, C. E., Mena, R. H., Velasco-Hernandez, J. X.
10.1101/2022.04.29.22274465 — Posted: 2022-05-01
Healthcare workers' mental health and wellbeing during the COVID-19 pandemic: Longitudinal analysis of interview and social media data
Vera San Juan, N., Martin, S., Badley, A., Maio, L., Gronholm, P., Buck, C., Flores, E., Vanderslott, S., Syversen, A., Mulcahy Symmons, S., Uddin, I., Karia, A., vindrola Padros, C.
10.1101/2022.04.29.22274481 — Posted: 2022-05-01
Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients
Thomson, T., Prendecki, M., Gleeson, S., Martin, P., Spensley, K. J., Cardoso De Aguiar, R., Sandhu, B., Seneschall, C., Gan, J., Clarke, C. L., Lewis, S., Pickard, G., Thomas, D., McAdoo, S. P., Lightstone, L., Cox, A., Kelleher, P., Willicombe, M.
10.1101/2022.04.29.22274396 — Posted: 2022-05-01
How did the COVID-19 pandemic affect access to condoms, chlamydia and HIV testing, and cervical cancer screening at a population level in Britain? (Natsal-COVID)
Dema, E., Sonnenberg, P., Gibbs, J., Conolly, A., Willis, M., Riddell, J., Boso Perez, R., Copas, A. J., Tanton, C., Bonell, C., Oeser, C., Clifton, S., Unemo, M., Mercer, C. H., Mitchell, K. R., Field, N.
10.1101/2022.04.29.22274486 — Posted: 2022-05-01
Quantifying the relationship between sub-population wastewater samples and community-wide SARS-CoV-2 seroprevalence
Smith, T., Holm, R. H., Keith, R. J., Amraotkar, A. R., Alvarado, C. R., Banecki, K., Choi, B., Santisteban, I. C., Bushau-Sprinkle, A. M., Kitterman, K. T., Fuqua, J., Hamorsky, K., Palmer, K. E., Brick, J. M., Rempala, G., Bhatnagar, A.
10.1101/2022.04.28.22274086 — Posted: 2022-05-01
Pre-morbid use of proton pump inhibitors has no effect on the risk of death or hospitalization in COVID-19 patients: a matched cohort study
Kodvanj, I., Homolak, J., Trkulja, V.
10.1101/2022.04.30.22274526 — Posted: 2022-05-01
Health-Related Quality of Life and Coping Strategies adopted by COVID-19 survivors: A nationwide cross-sectional study in Bangladesh
Hossain, M. A., Shafin, R., Ahmed, M. S., Rana, M. S., Walton, L. M., Raigangar, V., Ara, T., Rasel, M. A. H., Hossain, M. S., Kabir, M. F., Islam, M. R., Hasan, M. N., Hossain, D., Rumana, F. S., Jahid, I. K.
10.1101/2022.04.30.22274514 — Posted: 2022-05-01
Vaccine Stockpile Sharing For Selfish Objectives
Shivam, S., Weitz, J., Wardi, Y.
10.1101/2022.04.28.22274446 — Posted: 2022-05-01
Human behaviour, NPI and mobility reduction effects on COVID-19 transmission in different countries of the world
Mohammadi, Z., Cojocaru, M. G., Thommes, E. W.
10.1101/2022.04.29.22274485 — Posted: 2022-05-01
Forecast Intervals for Infectious Disease Models
Picard, R., Osthus, D.
10.1101/2022.04.29.22274494 — Posted: 2022-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).